miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/ß-catenin pathway.
Exp Mol Pathol
; 106: 34-43, 2019 02.
Article
in En
| MEDLINE
| ID: mdl-30539797
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
RNA, Neoplasm
/
Carcinoma, Hepatocellular
/
Drug Resistance, Neoplasm
/
Antineoplastic Agents, Alkylating
/
MicroRNAs
/
Wnt Signaling Pathway
/
Oxaliplatin
/
Liver Neoplasms
/
Neoplasm Proteins
Type of study:
Diagnostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Exp Mol Pathol
Year:
2019
Document type:
Article
Country of publication:
Netherlands